Search research articles
Contact Us
Filters
Showing results (321-330 of 2,971) with videos related to
Page
of 298
Sort By:
European Urology Oncology
|
February 28, 2024
Re: Ost P, Siva S, Brabrand S, et al. PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.007
Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, et al.
The Journal of Urology
|
July 31, 2024
Letter: Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer
Francesco Montorsi, Riccardo Leni, Alberto Briganti, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 2012
In reply to Yu
Alberto Briganti, Firas Abdollah, Francesco Montorsi, et al.
Clinical and Experimental Immunology
|
November 12, 2022
B cells in human lymphoid structures
Lucia Montorsi, Jacqueline H Y Siu, Jo Spencer
European Urology
|
May 20, 2026
Re: Christof Vulsteke, Nabil Adra, Pongwut Danchaivijitr, et al. Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. N Engl J Med 2026;394:1257-1269
Marco Moschini, Pietro Scilipoti, Mattia Longoni, et al.
The Journal of Urology
|
May 13, 2026
Interpreting Matched Analyses of Partial Versus Radical Nephrectomy for cT2 Tumors: Methodological Caveats and Clinical Implications
Umberto Capitanio, Francesco Cei, Alessandro Larcher, et al.
Minerva Chirurgica
|
August 1, 1990
[The Fitz-Hugh-Curtis syndrome. Postgonococcal perihepatitis]
M Strinna, C Voci, R Cavagnoli, et al.
European Urology Oncology
|
February 8, 2025
Re: Bertrand F. Tombal, Francisco Gomez-Veiga, Alvaro Gomez-Ferrer, et al. A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532). Eur Urol Oncol 2024;7:1051-60
Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, et al.
Future Oncology (London, England)
|
March 2, 2016
How can we optimize the use of prostate cancer registries?
Giorgio Gandaglia, Nicola Fossati, Francesco Montorsi, et al.
Comprehensive Reviews in Food Science and Food Safety
|
December 18, 2020
Meta-Analysis for Correlating Structure of Bioactive Peptides in Foods of Animal Origin with Regard to Effect and Stability
Elena Maestri, Milica Pavlicevic, Michela Montorsi, et al.
Page
of 298
Search research articles
Search
Showing results (321-330 of 2,971) with videos related to
Sort By:
Page
of 298
European Urology Oncology
|
February 28, 2024
Re: Ost P, Siva S, Brabrand S, et al. PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.007
Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, et al.
The Journal of Urology
|
July 31, 2024
Letter: Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer
Francesco Montorsi, Riccardo Leni, Alberto Briganti, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 1, 2012
In reply to Yu
Alberto Briganti, Firas Abdollah, Francesco Montorsi, et al.
Clinical and Experimental Immunology
|
November 12, 2022
B cells in human lymphoid structures
Lucia Montorsi, Jacqueline H Y Siu, Jo Spencer
European Urology
|
May 20, 2026
Re: Christof Vulsteke, Nabil Adra, Pongwut Danchaivijitr, et al. Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. N Engl J Med 2026;394:1257-1269
Marco Moschini, Pietro Scilipoti, Mattia Longoni, et al.
The Journal of Urology
|
May 13, 2026
Interpreting Matched Analyses of Partial Versus Radical Nephrectomy for cT2 Tumors: Methodological Caveats and Clinical Implications
Umberto Capitanio, Francesco Cei, Alessandro Larcher, et al.
Minerva Chirurgica
|
August 1, 1990
[The Fitz-Hugh-Curtis syndrome. Postgonococcal perihepatitis]
M Strinna, C Voci, R Cavagnoli, et al.
European Urology Oncology
|
February 8, 2025
Re: Bertrand F. Tombal, Francisco Gomez-Veiga, Alvaro Gomez-Ferrer, et al. A Phase 2 Randomized Open-label Study of Oral Darolutamide Monotherapy Versus Androgen Deprivation Therapy in Men with Hormone-sensitive Prostate Cancer (EORTC-GUCG 1532). Eur Urol Oncol 2024;7:1051-60
Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, et al.
Future Oncology (London, England)
|
March 2, 2016
How can we optimize the use of prostate cancer registries?
Giorgio Gandaglia, Nicola Fossati, Francesco Montorsi, et al.
Comprehensive Reviews in Food Science and Food Safety
|
December 18, 2020
Meta-Analysis for Correlating Structure of Bioactive Peptides in Foods of Animal Origin with Regard to Effect and Stability
Elena Maestri, Milica Pavlicevic, Michela Montorsi, et al.
Page
of 298